Literature DB >> 31434701

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements.

Ilaria Tanasi1,2, Ibrahima Ba3,4, Nicolas Sirvent5, Thorsten Braun6, Wendy Cuccuini3, Paola Ballerini7, Nicolas Duployez8, Aline Tanguy-Schmidt9,10,11, Jérôme Tamburini12, Sébastien Maury13, Eric Doré14, Chantal Himberlin15, Cédric Duclos16, Patrice Chevallier17, Philippe Rousselot18, Massimiliano Bonifacio2, Hélène Cavé19, André Baruchel20,21, Hervé Dombret1,21, Jean Soulier3,4, Judith Landman-Parker22, Nicolas Boissel1,21, Emmanuelle Clappier3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31434701     DOI: 10.1182/blood.2019001244

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  27 in total

1.  ABL-class fusion positive acute lymphoblastic leukemia: can targeting ABL cure ALL?

Authors:  Thai Hoa Tran; Stephen P Hunger
Journal:  Haematologica       Date:  2020-07       Impact factor: 9.941

Review 2.  Molecular markers in ALL: Clinical implications.

Authors:  Shunsuke Kimura; Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2020-06-07       Impact factor: 3.020

3.  MRD in adult Ph/BCR-ABL-negative ALL: how best to eradicate?

Authors:  Nicola Gökbuget
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?

Authors:  Thai Hoa Tran; Sarah K Tasian
Journal:  Best Pract Res Clin Haematol       Date:  2021-10-23       Impact factor: 3.020

Review 5.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 6.  Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Hiroto Inaba; Ching-Hon Pui
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

Review 7.  MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL.

Authors:  Manuela Tosi; Orietta Spinelli; Matteo Leoncin; Roberta Cavagna; Chiara Pavoni; Federico Lussana; Tamara Intermesoli; Luca Frison; Giulia Perali; Francesca Carobolante; Piera Viero; Cristina Skert; Alessandro Rambaldi; Renato Bassan
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 8.  Lymphoblastic Lymphoma: a Concise Review.

Authors:  Tamara Intermesoli; Alessandra Weber; Matteo Leoncin; Luca Frison; Cristina Skert; Renato Bassan
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

9.  Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.

Authors:  Sabina Chiaretti; Monica Messina; Irene Della Starza; Alfonso Piciocchi; Luciana Cafforio; Marzia Cavalli; Akram Taherinasab; Michela Ansuinelli; Loredana Elia; Guglielmo Albertini Petroni; Roberta La Starza; Martina Canichella; Alessia Lauretti; Maria Cristina Puzzolo; Valentina Pierini; Alessandra Santoro; Orietta Spinelli; Valerio Apicella; Saveria Capria; Francesco Di Raimondo; Paolo De Fabritiis; Cristina Papayannidis; Anna Candoni; Roberto Cairoli; Marco Cerrano; Nicola Fracchiolla; Daniele Mattei; Chiara Cattaneo; Antonella Vitale; Enrico Crea; Paola Fazi; Cristina Mecucci; Alessandro Rambaldi; Anna Guarini; Renato Bassan; Robin Foà
Journal:  Haematologica       Date:  2021-06-01       Impact factor: 9.941

Review 10.  Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.

Authors:  Ilaria Iacobucci; Kathryn G Roberts
Journal:  Genes (Basel)       Date:  2021-05-01       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.